SEI Investments’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-169,327
Closed -$215K 3338
2026
Q1
$215K Buy
169,327
+73,421
+77% +$138K ﹤0.01% 2955
2025
Q4
$229K Buy
+95,906
New +$262K ﹤0.01% 2842
2024
Q3
Sell
-17,893
Closed -$114K 2719
2024
Q2
$114K Sell
17,893
-3,931
-18% -$25.2K ﹤0.01% 2518
2024
Q1
$164K Buy
21,824
+1,648
+8% +$15K ﹤0.01% 2455
2023
Q4
$187K Sell
20,176
-2,889
-13% -$23.6K ﹤0.01% 2449
2023
Q3
$233K Sell
23,065
-30,575
-57% -$365K ﹤0.01% 2393
2023
Q2
$670K Buy
53,640
+40,822
+318% +$486K ﹤0.01% 2026
2023
Q1
$150K Buy
+12,818
New +$163K ﹤0.01% 2535
2022
Q4
Sell
-21,484
Closed -$208K 2599
2022
Q3
$208K Buy
21,484
+5,012
+30% +$66.4K ﹤0.01% 2432
2022
Q2
$228K Buy
+16,472
New +$281K ﹤0.01% 2442

Other funds holding HCAT

SEI Investments's HCAT Position: Q2 2026 in Review

SEI Investments sold out of Health Catalyst (HCAT) in Q2 2026, closing a stake of 169,327 shares — an estimated $215K sold.

SEI Investments first reported a position in HCAT in Q2 2022 and held it in 10 quarters. The position peaked at $670K in Q2 2023. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • SEI Investments reported no remaining Health Catalyst position as of Q2 2026 after selling out during the quarter.
  • SEI Investments sold 169,327 Health Catalyst shares in Q2 2026, an estimated $215K.
  • SEI Investments first reported a position in Health Catalyst in Q2 2022 and held it in 10 quarters.
  • SEI Investments's Health Catalyst position peaked at $670K in Q2 2023.
  • 126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.